Clinical Cases Podcast Series-FREE NO CME-Opioid Risks and Side Effects

Opioid Risks and Side Effects
Pdf Summary
The Compass Opioid Prescribing Treatment Guidance Toolkit outlines safe, limited opioid use for acute pain and emphasizes opioid risks and alternatives. Opioids should not be first-line therapy for mild to moderate acute pain in opioid-naïve patients; clinicians should prioritize nonpharmacologic and nonopioid treatments (e.g., acetaminophen and NSAIDs), which are often equally or more effective and safer.<br /><br />If opioids are considered, clinicians should: evaluate the pain type, severity, likely recovery time, and patient factors (age, comorbidities, alcohol/sedative use); maximize multimodal pain strategies; assess risk for opioid use disorder (including substance use history); consult the Prescription Drug Monitoring Program for controlled-substance history and concurrent benzodiazepine or chronic opioid use; and educate patients on expected recovery, functional goals, opioid risks/side effects, and safe storage/disposal.<br /><br />When prescribing, use the lowest effective dose of a short-acting, immediate-release single-entity opioid, typically for about 3 days, and up to 7 days only for more severe acute pain. Continue other effective pain interventions. Establish follow-up and reassess before refills using functional tools (e.g., PEG), document rapid risk assessment for opioid-related adverse drug events and OUD, and use controlled-substance agreements when applicable. Have a plan for tapering/discontinuation.<br /><br />The document details opioid dangers: rapid tolerance, severe withdrawal, misuse/addiction potential, and overdose risk (especially after abstinence). Common side effects include nausea/vomiting, constipation, pruritus, euphoria, lightheadedness, dry mouth, and GI slowing; serious harms include respiratory depression (worsened by alcohol/benzodiazepines), cardiac arrhythmias, hormonal and fertility disruption, osteoporosis risk, immunosuppression, hyperalgesia, and sleep disturbance.<br /><br />It recommends maintaining a “no-opioid” list for conditions with poor evidence of benefit (e.g., uncomplicated low back pain, dental pain, migraine/post-traumatic headache, many musculoskeletal injuries, neuropathic pain, cyclic vomiting, and previously reduced fractures/dislocations). It also encourages tracking and sharing clinician prescribing patterns for quality improvement and notes opioid selection may vary by comorbidities (renal/hepatic disease, constipation risk, serotonin syndrome risk) and practical factors like formulary and coverage.
Keywords
opioid prescribing
acute pain
nonopioid alternatives
NSAIDs
acetaminophen
Prescription Drug Monitoring Program
opioid risks
short-acting opioids
tapering
no-opioid list